The Crossroads of Neuroinflammation and Biomarkers in Multiple Sclerosis: A Systematic Review
Overview of Neuroinflammation in Multiple Sclerosis Neuroinflammation plays a pivotal role in the pathophysiology of Multiple Sclerosis (MS), a chronic […]
Overview of Neuroinflammation in Multiple Sclerosis Neuroinflammation plays a pivotal role in the pathophysiology of Multiple Sclerosis (MS), a chronic […]
Study Objectives The primary aim of this research was to explore the existence of distinct neuropsychiatric subtypes within patients diagnosed
Gender Disparities in Neuropsychiatric Disorders The prevalence of neuropsychiatric disorders exhibits marked gender disparities, with many conditions demonstrating a significant
Patient Demographics The demographic profile of patients hospitalized with traumatic brain injury (TBI) provides valuable insights into the population affected
Technological Advances in Concussion Prevention Recent developments in technology are playing a crucial role in enhancing the safety of young
Longitudinal Impact on Health Outcomes The long-term consequences of pediatric concussions can have significant implications for individuals as they transition
Longitudinal effects of pediatric concussion into adulthood Read Post »
Neuropsychiatric Effects of Concussions Concussions, a form of mild traumatic brain injury, can have profound neuropsychiatric consequences that extend beyond
Neuropsychiatric sequelae of single and repetitive concussions Read Post »
Evidence-Based Approach Implementing an evidence-based approach in managing adult concussions involves systematically integrating clinical expertise with the best available research
Evidence-based Management Strategies for Adult Concussion Read Post »
Longitudinal Impact of Concussion The consequences of pediatric concussion can have far-reaching and lasting effects into adulthood. Research shows that
Longitudinal effects of pediatric concussion into adulthood Read Post »
MOG Antibody-Associated Disease Overview Myelin Oligodendrocyte Glycoprotein (MOG) antibodies are increasingly recognized as significant biomarkers in a subset of neurological